Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Maveyraud,
H.Niwa,
V.Guillet,
D.I.Svergun,
P.V.Konarev,
R.A.Palmer,
W.J.Peumans,
P.Rougé,
E.J.Van Damme,
C.D.Reynolds,
and
L.Mourey
(2009).
Structural basis for sugar recognition, including the Tn carcinoma antigen, by the lectin SNA-II from Sambucus nigra.
|
| |
Proteins, 75,
89.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.L.Quillin,
P.T.Wingfield,
and
B.W.Matthews
(2006).
Determination of solvent content in cavities in IL-1beta using experimentally phased electron density.
|
| |
Proc Natl Acad Sci U S A, 103,
19749-19753.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.G.Rudolph,
M.S.Kelker,
T.R.Schneider,
T.O.Yeates,
V.Oseroff,
D.K.Heidary,
P.A.Jennings,
and
I.A.Wilson
(2003).
Use of multiple anomalous dispersion to phase highly merohedrally twinned crystals of interleukin-1beta.
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
290-298.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Vitkup,
D.Ringe,
M.Karplus,
and
G.A.Petsko
(2002).
Why protein R-factors are so large: a self-consistent analysis.
|
| |
Proteins, 46,
345-354.
|
 |
|
|
|
|
 |
J.R.Hea,
S.Bino,
G.W.Roberts,
J.G.Raynes,
and
A.D.Miller
(2002).
Mechanistic investigation into complementary (antisense) peptide mini-receptor inhibitors of cytokine interleukin-1.
|
| |
Chembiochem, 3,
76-85.
|
 |
|
|
|
|
 |
J.L.Barton,
R.Herbst,
D.Bosisio,
L.Higgins,
and
M.J.Nicklin
(2000).
A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities.
|
| |
Eur J Immunol, 30,
3299-3308.
|
 |
|
|
|
|
 |
Y.Liu,
A.J.Chirino,
Z.Misulovin,
C.Leteux,
T.Feizi,
M.C.Nussenzweig,
and
P.J.Bjorkman
(2000).
Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand.
|
| |
J Exp Med, 191,
1105-1116.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.K.Dattagupta,
A.Podder,
C.Chakrabarti,
U.Sen,
D.Mukhopadhyay,
S.K.Dutta,
and
M.Singh
(1999).
Refined crystal structure (2.3 A) of a double-headed winged bean alpha-chymotrypsin inhibitor and location of its second reactive site.
|
| |
Proteins, 35,
321-331.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Ravichandran,
U.Sen,
C.Chakrabarti,
and
J.K.Dattagupta
(1999).
Cryocrystallography of a Kunitz-type serine protease inhibitor: the 90 K structure of winged bean chymotrypsin inhibitor (WCI) at 2.13 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr, 55,
1814-1821.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.D.Osslund,
R.Syed,
E.Singer,
E.W.Hsu,
R.Nybo,
B.L.Chen,
T.Harvey,
T.Arakawa,
L.O.Narhi,
A.Chirino,
and
C.F.Morris
(1998).
Correlation between the 1.6 A crystal structure and mutational analysis of keratinocyte growth factor.
|
| |
Protein Sci, 7,
1681-1690.
|
 |
|
|
|
|
 |
C.Chothia,
T.Hubbard,
S.Brenner,
H.Barns,
and
A.Murzin
(1997).
Protein folds in the all-beta and all-alpha classes.
|
| |
Annu Rev Biophys Biomol Struct, 26,
597-627.
|
 |
|
|
|
|
 |
T.R.Transue,
A.K.Smith,
H.Mo,
I.J.Goldstein,
and
M.A.Saper
(1997).
Structure of benzyl T-antigen disaccharide bound to Amaranthus caudatus agglutinin.
|
| |
Nat Struct Biol, 4,
779-783.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.S.Chang,
R.M.Beauvais,
T.Arakawa,
L.O.Narhi,
A.Dong,
D.I.Aparisio,
and
J.F.Carpenter
(1996).
Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.
|
| |
Biophys J, 71,
3399-3406.
|
 |
|
|
|
|
 |
D.C.Ambrosetti,
E.Palla,
A.Mirtella,
C.Galeotti,
E.Solito,
P.Navarra,
L.Parente,
and
M.Melli
(1996).
Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.
|
| |
Eur J Biochem, 238,
308-316.
|
 |
|
|
|
|
 |
L.Zhang,
and
J.Hermans
(1996).
Hydrophilicity of cavities in proteins.
|
| |
Proteins, 24,
433-438.
|
 |
|
|
|
|
 |
M.Blaber,
J.DiSalvo,
and
K.A.Thomas
(1996).
X-ray crystal structure of human acidic fibroblast growth factor.
|
| |
Biochemistry, 35,
2086-2094.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Iwata,
A.Kasuya,
and
S.Miyamoto
(1996).
Reconstruction of the 3D coordinates of alpha-carbon atoms of proteins from a pair of stereographic figures.
|
| |
J Comput Aided Mol Des, 10,
558-566.
|
 |
|
|
|
|
 |
Y.Kato,
T.Muto,
T.Tomura,
H.Tsumura,
H.Watarai,
T.Mikayama,
K.Ishizaka,
and
R.Kuroki
(1996).
The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets.
|
| |
Proc Natl Acad Sci U S A, 93,
3007-3010.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.A.Schreuder,
J.M.Rondeau,
C.Tardif,
A.Soffientini,
E.Sarubbi,
A.Akeson,
T.L.Bowlin,
S.Yanofsky,
and
R.W.Barrett
(1995).
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.
|
| |
Eur J Biochem, 227,
838-847.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.B.Swindells
(1995).
A procedure for the automatic determination of hydrophobic cores in protein structures.
|
| |
Protein Sci, 4,
93.
|
 |
|
|
|
|
 |
S.A.Greenfeder,
T.Varnell,
G.Powers,
K.Lombard-Gillooly,
D.Shuster,
K.W.McIntyre,
D.E.Ryan,
W.Levin,
V.Madison,
and
G.Ju
(1995).
Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity.
|
| |
J Biol Chem, 270,
22460-22466.
|
 |
|
|
|
|
 |
U.Kavita,
and
S.B.Mizel
(1995).
Differential sensitivity of interleukin-1 alpha and -beta precursor proteins to cleavage by calpain, a calcium-dependent protease.
|
| |
J Biol Chem, 270,
27758-27765.
|
 |
|
|
|
|
 |
G.M.Clore,
and
A.M.Gronenborn
(1994).
Young Investigator Award Lecture. Structures of larger proteins, protein-ligand and protein-DNA complexes by multidimensional heteronuclear NMR.
|
| |
Protein Sci, 3,
372-390.
|
 |
|
|
|
|
 |
A.E.Eriksson,
L.S.Cousens,
and
B.W.Matthews
(1993).
Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.
|
| |
Protein Sci, 2,
1274-1284.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Guinet,
J.D.Guitton,
N.Gault,
F.Folliard,
N.Touchet,
J.M.Cherel,
A.Crespo,
A.Destourbe,
P.Bertrand,
and
P.Denefle
(1993).
Interleukin-1 beta-specific partial agonists defined by site-directed mutagenesis studies.
|
| |
Eur J Biochem, 211,
583-590.
|
 |
|
|
|
|
 |
A.W.Yem,
D.M.Guido,
W.R.Mathews,
N.D.Staite,
K.A.Richard,
M.D.Prairie,
W.C.Krueger,
D.E.Epps,
and
M.R.Deibel
(1992).
Chemical modification of interleukin-1 beta: biochemical characterization of a carbodiimide-catalyzed intramolecular cross-linked protein.
|
| |
J Protein Chem, 11,
709-722.
|
 |
|
|
|
|
 |
B.Veerapandian,
G.L.Gilliland,
R.Raag,
A.L.Svensson,
Y.Masui,
Y.Hirai,
and
T.L.Poulos
(1992).
Functional implications of interleukin-1 beta based on the three-dimensional structure.
|
| |
Proteins, 12,
10-23.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Veerapandian
(1992).
Structure and function of interleukin-1, based on crystallographic and modeling studies.
|
| |
Biophys J, 62,
112-115.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.A.Stura,
P.Chen,
C.M.Wilmot,
J.H.Arevalo,
and
I.A.Wilson
(1992).
Crystallization studies of glycosylated and unglycosylated human recombinant interleukin-2.
|
| |
Proteins, 12,
24-30.
|
 |
|
|
|
|
 |
M.Billeter
(1992).
Comparison of protein structures determined by NMR in solution and by X-ray diffraction in single crystals.
|
| |
Q Rev Biophys, 25,
325-377.
|
 |
|
|
|
|
 |
M.D.Walkinshaw
(1992).
Protein targets for structure-based drug design.
|
| |
Med Res Rev, 12,
317-372.
|
 |
|
|
|
|
 |
P.Manavalan,
D.L.Swope,
and
R.M.Withy
(1992).
Sequence and structural relationships in the cytokine family.
|
| |
J Protein Chem, 11,
321-331.
|
 |
|
|
|
|
 |
T.Senda,
T.Shimazu,
S.Matsuda,
G.Kawano,
H.Shimizu,
K.T.Nakamura,
and
Y.Mitsui
(1992).
Three-dimensional crystal structure of recombinant murine interferon-beta.
|
| |
EMBO J, 11,
3193-3201.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.E.Eriksson,
L.S.Cousens,
L.H.Weaver,
and
B.W.Matthews
(1991).
Three-dimensional structure of human basic fibroblast growth factor.
|
| |
Proc Natl Acad Sci U S A, 88,
3441-3445.
|
 |
|
|
|
|
 |
C.S.Wu,
S.A.Thompson,
and
J.T.Yang
(1991).
Basic fibroblast growth factor is a beta-rich protein.
|
| |
J Protein Chem, 10,
427-436.
|
 |
|
|
|
|
 |
D.A.Parry,
E.Minasian,
and
S.J.Leach
(1991).
Cytokine conformations: predictive studies.
|
| |
J Mol Recognit, 4,
63-75.
|
 |
|
|
|
|
 |
E.Labriola-Tompkins,
C.Chandran,
K.L.Kaffka,
D.Biondi,
B.J.Graves,
M.Hatada,
V.S.Madison,
J.Karas,
P.L.Kilian,
and
G.Ju
(1991).
Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
|
| |
Proc Natl Acad Sci U S A, 88,
11182-11186.
|
 |
|
|
|
|
 |
G.Ju,
E.Labriola-Tompkins,
C.A.Campen,
W.R.Benjamin,
J.Karas,
J.Plocinski,
D.Biondi,
K.L.Kaffka,
P.L.Kilian,
and
S.P.Eisenberg
(1991).
Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
|
| |
Proc Natl Acad Sci U S A, 88,
2658-2662.
|
 |
|
|
|
|
 |
J.D.Zhang,
L.S.Cousens,
P.J.Barr,
and
S.R.Sprang
(1991).
Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.
|
| |
Proc Natl Acad Sci U S A, 88,
3446-3450.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.P.Eisenberg,
M.T.Brewer,
E.Verderber,
P.Heimdal,
B.J.Brandhuber,
and
R.C.Thompson
(1991).
Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism.
|
| |
Proc Natl Acad Sci U S A, 88,
5232-5236.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|